W Biernacki
About
In The Last Decade
W Biernacki
15 papers receiving 649 citations
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 463
- Physiology 243
- Molecular Biology 117
- Cardiology and Cardiovascular Medicine 83
- Biomedical Engineering 71
Countries citing papers authored by W Biernacki
This map shows the geographic impact of W Biernacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Biernacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Biernacki more than expected).
Fields of papers citing papers by W Biernacki
This network shows the impact of papers produced by W Biernacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Biernacki. The network helps show where W Biernacki may publish in the future.
Co-authorship network of co-authors of W Biernacki
This figure shows the co-authorship network connecting the top 25 collaborators of W Biernacki. A scholar is included among the top collaborators of W Biernacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Biernacki. W Biernacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | 206 | |
| 3 | 40 | |
| 4 | 90 | |
| 5 | 46 | |
| 6 | 58 | |
| 7 | [Evaluation of emphysema progression as measured by computed tomography in patients with chronic obstructive pulmonary disease]. | 2 |
| 8 | 16 | |
| 9 | 55 | |
| 10 | 7 | |
| 11 | Doxazosin, a new alpha-1-antagonist drug, controls hypertension without causing airways obstruction in asthma and COPD. | 6 |
| 12 | Measurement of right ventricular dimensions in chronic obstructive pulmonary disease using magnetic resonance imaging | 1 |
| 13 | 64 | |
| 14 | 50 | |
| 15 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.